Prostate Cancer Coverage From Every Angle

Recent News

AACR 2019: Abiraterone Acetate and Preexisting Cardiovascular Disease in Patients With Prostate Cancer
Targeting Fatty Acid Transporter to Prevent Disease Progression in Prostate Cancer
2019 ASCO-SITC: Genetic Characterization of BRCA-Mutant Prostate Cancer
2019 GU Symposium: Survival May Vary by Race in Some Patients Treated for Prostate Cancer
2019 GU Symposium: Nivolumab Plus Ipilimumab in Metastatic Castration-Resistant Prostate Cancer
2019 GU Symposium: Novel Radiolabeled Therapy for Resistant Prostate Cancer
Prostate Cancer Outcomes: Evaluation of Gleason Score and Race
Use of Finasteride and Prostate Cancer–Specific Mortality
Germline DNA Repair Mutations and Prognosis in Castration-Resistant Prostate Cancer
Outcomes After Radical Prostatectomy: Very High–Risk vs. High-Risk Patients
Northwestern Medicine Receives $10 Million Gift to Create Urologic Cancer Institute
Cyclohexanone Curcumin Analogs May Hinder Progression of Castration-Resistant Prostate Cancer
Predicting Aggressive Prostate Cancer in Black Men
NICE Recommends Noninvasive MRI Screening for Prostate Cancer
Clinical Practice Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer
Does the Timing of Androgen-Deprivation Therapy Affect Outcomes in Prostate Cancer?
Shedding Light on Resistance to Hormone Therapy in Prostate Cancer
Chemoradiotherapy Plus Hormonal Therapy in Localized Prostate Cancer: Late Toxicity Analysis
NCRI Cancer Conference: Men With Prostate Cancer Balance Quality of Life and Survival
ESMO 2018: Responses to Rucaparib in Men With HRR-Deficient Prostate Cancer
ESMO 2018: Enzalutamide in Men With Nonmetastatic Castration-Resistant Prostate Cancer
ASTRO 2018: Response to Radiotherapy in African American Men With Prostate Cancer
ESMO 2018: Does Local Radiotherapy Improve Survival in Some Men With Prostate Cancer?
ASTRO 2018: Stereotactic Body Radiation for Low- and Intermediate-Risk Prostate Cancer
ESMO 2018: 12-Year Follow-up With Docetaxel-Based Chemotherapy in High-Risk Prostate Cancer
International Cancer Immunotherapy Conference: Early Study Results of Vaccine in HER2-Positive Cancers
Prostate Cancer Foundation Releases First National Report on Prostate Cancer Awareness
FDA Grants Breakthrough Therapy Designation to Rucaparib in Metastatic Prostate Cancer
Is Alcohol Intake Earlier in Life Associated With High-Grade Prostate Cancer?
Updated NCCN Guidelines for Prostate Cancer: New Treatment Options Added
Prostate Cancer Research Funded by U.S. Department of Defense

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.